Emboline, an emerging medical device company, has raised $10 million in a Series B round to get its embolic protection technology on the market in Europe.
Robotics, pricing concerns, and the prevalence of more procedures being performed at ambulatory centers are some of the hot topics in the orthopedics market.
Intersect ENT brings its fourth commercial product, the Sinuva Sinus implant, to market to treat nasal polyp disease.
SetPoint Medical launches 15-patient pilot trial for its miniaturized vagus nerve stimulation device to treat RA.
Edwards Lifesciences plans to submit additional data for the Sapien 3 Ultra valve before it files for CE mark, causing a slight delay in the product getting to the market.
Colibri has treated the first two patients in a feasibility study and cites Edwards Lifesciences as its main competition in the TAVR market.
FDA gave the company the green light to end a trial of its LAP-BAND System early, saving the company more than $5 million.
FDA Commissioner Scott Gottlieb updated the public regarding the agency's ongoing post-market review of the controversial birth control device, but patient advocacy group Essure Problems says the commissioner's words are just another letdown.
Spinal implant manufacturers have to be able to spot gaps where products are underutilized and need evidence-supported arguments along with value propositions to be successful in the market place.
Investors ranging from Google's parent company to pharma giants Novartis and AstraZeneca have shown interest in Rani Therapeutics, which is developing an ingestible drug-delivery pill.
FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.
Through the process of electrochemical etching, researchers created a nanotextured material for stainless steel surfaces that can kill bacteria without harming cells.